GRI Bio, Inc
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GRI Bio, Inc and other ETFs, options, and stocks.About GRI
GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis.
CEOW. Marc Hertz
CEOW. Marc Hertz
Employees4
Employees4
HeadquartersLa Jolla, California
HeadquartersLa Jolla, California
Founded2009
Founded2009
Employees4
Employees4
GRI Key Statistics
Market cap3.47M
Market cap3.47M
Price-Earnings ratio-0.05
Price-Earnings ratio-0.05
Dividend yield—
Dividend yield—
Average volume103.43K
Average volume103.43K
High today$1.56
High today$1.56
Low today$1.35
Low today$1.35
Open price$1.42
Open price$1.42
Volume83.88K
Volume83.88K
52 Week high$30.43
52 Week high$30.43
52 Week low$1.10
52 Week low$1.10
GRI News
TipRanks 4d
GRI Bio Advances with Positive GRI-0621 DataElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
People also own
Based on the portfolios of people who own GRI. This list is generated using Robinhood data, and it’s not a recommendation.